Attached files
file | filename |
---|---|
10-K/A - EFT Holdings, Inc. | v163076_10ka.htm |
EX-31.2 - EFT Holdings, Inc. | v163076_ex31-2.htm |
EX-31.1 - EFT Holdings, Inc. | v163076_ex31-1.htm |
EX-32.1 - EFT Holdings, Inc. | v163076_ex32-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the accompanying Annual Report on Form 10-K Amendment No. 2 of
EFT BioTech Holdings, Inc. (the “Company”) for the fiscal year ended March 31,
2009, I, Sharon Tang, the Chief Financial Officer (Principal Financial and
Accounting Officer) of the Company hereby certify pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
the best of my knowledge and belief, that:
1.
|
Such
Annual Report on Form 10-K Amendment No. 2 for the year ending March 31,
2009 fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in such Annual Report on Form 10-K Amendment No. 2
for the fiscal year ended March 31, 2009 fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Dated:
October 19, 2009
|
||
/s/
Sharon Tang
|
||
Sharon
Tang
|
||
Chief
Financial Officer
|
||
(Principal
Financial and Accounting
Officer)
|